Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas

被引：0
|
作者：
Tamara Ius
Daniela Cesselli
Miriam Isola
Giovanni Toniato
Giada Pauletto
Giovanni Sciacca
Sara Fabbro
Enrico Pegolo
Simona Rizzato
Antonio Paolo Beltrami
Carla di Loreto
Miran Skrap
机构：
[1] Santa Maria della Misericordia University Hospital,Neurosurgery Unit, Department of Neurosciences
[2] University of Udine,Department of Medicine
[3] Santa Maria della Misericordia University Hospital,Neurology Unit, Department of Neurosciences
[4] Santa Maria della Misericordia University Hospital,Department of Oncology
[5] Santa Maria della Misericordia University Hospital,Institute of Pathology
来源：
Current Treatment Options in Neurology | 2018年 / 20卷
关键词：
Glioma surgery; Carmustine wafers; MGMT methylation; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Feasibility of lymphocyte harvesting and reinfusion in patients with newly diagnosed high-grade gliomas.
    Campian, Jian Li
    Ye, Xiaobu
    Gladstone, Douglas Edward
    Ambady, Prakash
    Borrello, Ivan
    Golightly, Marc
    Karen, Karen E. King
    King, E.
    Holdhoff, Matthias
    Karp, Judith E.
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Elevated factor VIII activity is common in patients with newly diagnosed high-grade gliomas
    Streiff, M. B.
    Grossman, S. A.
    Ye, X.
    Kickler, T. S.
    Lesser, G. J.
    Batchelor, T. T.
    Jani, J. T.
    Desideri, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Reported outcomes of children with newly diagnosed high-grade gliomas treated with nimotuzumab and irinotecan
    Nongnuch Sirachainan
    Atthaporn Boongird
    Thiti Swangsilpa
    Wipawi Klaisuban
    Apasri Lusawat
    Suradej Hongeng
    Child's Nervous System, 2017, 33 : 893 - 897
  • [34] Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomas
    Kesari, Santosh
    Wojcinski, Alexandre
    Pabla, Sarabjot
    Seager, R. J.
    Gill, Jaya M.
    Carrillo, Jose A.
    Wagle, Naveed
    Park, David J.
    Nguyen, Minhdan
    Truong, Judy
    Takasumi, Yuki
    Chaiken, Lisa
    Chang, Shu-Ching
    Barkhoudarian, Garni
    Kelly, Daniel F.
    Juarez, Tiffany M.
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [35] Severe thrombocytopenia from temozolomide (TMZ) in newly diagnosed patients with high-grade gliomas.
    Gerber, David E.
    Grossman, Stuart A.
    CANCER RESEARCH, 2006, 66 (08)
  • [36] Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas
    Fine, HA
    Wen, PY
    Maher, EA
    Viscosi, E
    Batchelor, T
    Lakhani, N
    Figg, WD
    Purow, BW
    Borkowf, CB
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2299 - 2304
  • [37] Effect of standard therapy on lymphocyte subsets and cytokines in newly diagnosed high-grade gliomas (HGG).
    Balmanoukian, A. S.
    Grossman, S. A.
    Thoburn, C.
    Kos, F.
    Holdhoff, M.
    Hess, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas
    Xie, Tian
    Guo, Xiaoyu
    Duan, Hao
    He, Zhenqiang
    Mou, Yonggao
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 201
  • [39] Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas
    Eberlein, Klaus H.
    Nagel, Britta
    Franz, Kea
    Imhoff, Detlef
    Seifert, Volker
    Boettcher, Heinz D.
    Mose, Stephan
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4959 - 4964
  • [40] RETROSPECTIVE COMPARISON OF CHEMORADIOTHERAPY FOLLOWED BY ADJUVANT CHEMOTHERAPY, WITH OR WITHOUT PRIOR GLIADEL IMPLANTATION (CARMUSTINE) AFTER INITIAL SURGERY IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS
    Noel, Georges
    Schott, Roland
    Froelich, Sebastien
    Gaub, Marie-Pierre
    Boyer, Patrick
    Fischer-Lokou, David
    Dufour, Patrick
    Kehrli, Pierre
    Maitrot, Daniel
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 749 - 755
12345